Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05988931 · ClinicalTrials.gov registry record · NA

Technology Interventions for Youth Alcohol Use

A NA study of Alcohol Drinking, sponsored by University of Michigan.

Recruiting
Registry status
NA
Development phase
1,400
Enrollment target
1
Study location

NCT05988931: Recruiting NA study of Alcohol Drinking, sponsored by University of Michigan.

NCT05988931 is a NA study of Alcohol Drinking that is actively recruiting participants, run by University of Michigan. The registered enrollment target is 1,400 participants, above the 614-participant average among 85 other Alcohol Drinking trials with a reported enrollment target (128% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05988931, a NA study of Alcohol Drinking, is actively recruiting participants, sponsored by University of Michigan.

RECRUITING
Registry status
NA
Development phase
1,400 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to evaluate the effects of two programs to prevent/reduce alcohol misuse among youth primary care patients. Depending on their study condition, youth will receive a brief web-based computer program or the web program + 8 weeks of supportive text messages. Parents/caregivers of youth are encouraged to use a freely available app to guide conversations with their child about drinking. This study will have significant impact by evaluating response to these scalable interventions which can be deployed widely in clinical care settings.

Primary Outcome

Alcohol consumption will be measured using total score on the 3-item Alcohol Use Disorders Identification Test-Consumption (AUDIT-C) which includes typical quantity and frequency, and frequency of binge drinking (# of drinks modified by age based on the NIAAA Youth Guide). Higher score indicates worse outcomes.

Conditions Studied

Interventions

  • BEHAVIORAL Web Program + App
  • BEHAVIORAL Web Program + App + Text Messages

Study Locations (1)

Michigan

  • University of Michigan - Ann Arbor

Trial Details

FieldValue
Enrollment Target 1,400 participants
Start Date 2023-10-25
Est. Completion 2027-09
Phase NA
University of Michigan

1,327 total trials

What NCT05988931 shows while recruiting

NCT05988931 is an interventional study that assigns participants to a tested intervention. Its 1,400 participants enrollment target places it among the larger protocols in the corpus, above the 614-participant average among 85 other Alcohol Drinking trials with a reported enrollment target (128% higher).

The record links to 1 condition, with Alcohol Drinking appearing as the primary indexed condition, and to 2 interventions - of which Web Program + App is the first listed.

NCT05988931 reports a single indexed study location in Michigan.

Frequently Asked Questions

What is clinical trial NCT05988931 about?

NCT05988931 is a clinical study titled "Technology Interventions for Youth Alcohol Use". The purpose of this study is to evaluate the effects of two programs to prevent/reduce alcohol misuse among youth primary care patients. Depending on their study condition, youth will receive a brief web-based computer program or the web program + 8 weeks of supportive text messages. Parents/caregiv...

What is the current status of trial NCT05988931?

This trial is currently recruiting. It is a NA study. The enrollment target is 1,400 participants. The study started on 2023-10-25. Estimated completion is 2027-09.

What conditions does trial NCT05988931 study?

This clinical trial studies the following conditions: Alcohol Drinking.

What interventions are being tested in trial NCT05988931?

The interventions under investigation include: Web Program + App (BEHAVIORAL), Web Program + App + Text Messages (BEHAVIORAL).

Who is sponsoring clinical trial NCT05988931?

This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05988931 being conducted?

This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Alcohol Drinking

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT05988931's enrollment target sits among peer trials

1,400 6th of 85 higher than 80 of 85 other Alcohol Drinking trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Alcohol Drinking trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02205762 · 1,400 participants · Phase 2

    LCH-IV, International Collaborative Treatment Protocol for Children and Adolescents With Langerhans Cell Histiocytosis

  • NCT02445222 · 1,400 participants · Phase 3

    CAR-T Long Term Follow Up (LTFU) Study

  • NCT03145077 · 1,400 participants · NA

    Dynamic Contrast-Enhanced Magnetic Resonance Imaging in Diagnosing Osteoradionecrosis in Patients With Head and Neck Cancer That Is Primary, Has Come Back, or Has Spread to Other Places in the Body

  • NCT04250857 · 1,400 participants

    HeartStart FRx Defibrillator Event Registry

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05988931, the US trial registry maintained by the National Library of Medicine. NCT05988931 (large enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.